PharmaControl Corp said it  acquired Private Formulations Inc from &lt;Revco D.S. Inc> for six  mln dlrs in cash, a 13,550,000 dlr promissory note and warrants  to buy 200,000 PharmaControl common shares.
The company said betweenm 11,550,000 dlrs and 12,550,000  dlrs f the principal amount of the Revco note, plus accrued  interest, is payable June 30.
Upon closing of the public offering, the company said, it  expects the secured institutional financing to increase to a  total of 12 mln dlrs.